Etiology and management evaluation of community acquired pneumonia;Evaluación de la etiología y del abordaje terapéutico de la neumonía adquirida en la comunidad

Medicina Clinica

Volumn 116, Issue 5, 2001, Pages 179-181

  Tores, A ^a   Soler, N ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIMICROBIAL ACTIVITY; BRONCHIECTASIS; CHLAMYDOPHILA PNEUMONIAE; COMORBIDITY; EDITORIAL; HAEMOPHILUS INFLUENZAE; HUMAN; LEGIONELLA PNEUMOPHILA; MYCOPLASMA PNEUMONIAE; PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TREATMENT PLANNING;

EID: 0035835301     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(01)71763-0     Document Type: Editorial

References (20)

1. Premature deaths, monthly mortality, and monthly physician contacts-United States
2. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio
3. Prognosis and outcomes of patients with community-acquire pneumonia
4. Community-acquired pneumonia
5. Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy
6. Guidelines for management of adult community-acquired lower respiratory tract infections
7. Tratamiento antibiótico empírico inicial de la NAC
8. Practice guidelines for the management of community-acquired pneumonia in adults
9. Etiology of community-acquired pneumonia: Impact of age, comorbidity and severity
10. Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognosis
11. Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae
12. Community-acquired pneumonia in chronic obstructive pulmonary disease
13. Severe community-acquired pneumonia
14. Severe community-acquired pneumonia: Risk factors and follow-up epidemiology
15. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance. 1995-1997
16. Centers for disease control and prevention. Treatment of community-acquired pneumonia
17. S. pneumoniae community-acquired pneumonia (SP-CAP). Antibiotic susceptibility in Spain
18. Estudio prospectivo de 221 neumonías adquiridas en la comunidad seguidas de forma ambulatoria. Etiología y evolución clinicorradiolȯgica
19. Infections caused by erythromycin resistant Streptococcus pneumoniae: Incidence, risk factors and response to therapy in a prospective study
20. Medical outcomes and antimicrobials costs with the use of American Thoracic Society guidelines for outpatients with community-acquired pneumonia